StonvexLoading…
StonvexStonvexStonvexCore line items from UGRO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $9.51M | $40.01M | $43.24M | $33.35M |
Operating Income | $-618.90K | $-28.42M | $-9.02M | $-5.16M |
Net Income | $-4.03M | $-36.50M | $-9.28M | $-2.96M |
EPS (Diluted) | $-7.78 | $-2.62 | $-0.76 | $-11.19 |
Total Assets | $16.09M | $19.49M | $49.21M | $55.01M |
Total Liabilities | $44.33M | $44.14M | $46.81M | $49.20M |
Cash & Equivalents | $697.00K | $819.05K | $1.14M | $384.80K |
Free Cash Flow OCF − CapEx | $2.15M | $-2.95M | $-844.50K | $-1.81M |
Shares Outstanding | 13.11M | 504.86K | 12.61M | 12.56M |